Your browser doesn't support javascript.
loading
The Application of and Strategy for Gold Nanoparticles in Cancer Immunotherapy.
He, Jia-Shuai; Liu, Shi-Jin; Zhang, Yi-Ran; Chu, Xiao-Dong; Lin, Zheng-Bin; Zhao, Zhan; Qiu, Sheng-Hui; Guo, Yan-Guan; Ding, Hui; Pan, Yun-Long; Pan, Jing-Hua.
Afiliação
  • He JS; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Liu SJ; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Zhang YR; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Chu XD; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Lin ZB; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Zhao Z; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Qiu SH; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Guo YG; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Ding H; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Pan YL; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
  • Pan JH; Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Front Pharmacol ; 12: 687399, 2021.
Article em En | MEDLINE | ID: mdl-34163367
Immunotherapy of malignant tumor is a verified and crucial anti-tumor strategy to help patients with cancer for prolonging prognostic survival. It is a novel anticancer tactics that activates the immune system to discern and damage cancer cells, thereby prevent them from proliferating. However, immunotherapy still faces many challenges in view of clinical efficacy and safety issues. Various nanomaterials, especially gold nanoparticles (AuNPs), have been developed not only for anticancer treatment but also for delivering antitumor drugs or combining other treatment strategies. Recently, some studies have focused on AuNPs for enhancing cancer immunotherapy. In this review, we summarized how AuNPs applicated as immune agents, drug carriers or combinations with other immunotherapies for anticancer treatment. AuNPs can not only act as immune regulators but also deliver immune drugs for cancer. Therefore, AuNPs are candidates for enhancing the efficiency and safety of cancer immunotherapy.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça